Pfizer

Pfizer reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 1,172 Kt (-10 /-0.8% y-o-y). Also positively, carbon intensity tumbled to 14 t (-14 /-49.3% y-o-y).

Pfizer's Scope 3 emissions plummeted to 3,818 Kt (-1,890 /-33.1% y-o-y). There has been no consistent trend in recent years.

The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -54 Kt per annum over the period of FY2022 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Pfizer aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2030. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.